Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Royalty Pharma

    NASDAQ: RPRX · Real-Time Price · USD
    35.09
    0.25 (0.72%)
    At close: Jun 16, 2025, 3:59 PM
    34.00
    -3.11%
    After-hours: Jun 16, 2025, 07:57 PM EDT

    Royalty Pharma Statistics

    Share Statistics

    Royalty Pharma has 562.29M shares outstanding. The number of shares has increased by -4.15% in one year.

    Shares Outstanding

    n/a
    		 562.29M

    Shares Change (YoY)

    n/a
    		 -4.15%

    Shares Change (QoQ)

    n/a
    		 -2.47%

    Owned by Institutions (%)

    n/a
    		 71.6%

    Shares Floating

    n/a
    		 443.35M

    Failed to Deliver (FTD) Shares

    n/a
    		 548

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 29.02M, so 6.89% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 29.02M

    Short % of Shares Out

    n/a
    		 6.89%

    Short % of Float

    n/a
    		 7%

    Short Ratio (days to cover)

    n/a
    		 3.75

    Valuation Ratios

    The PE ratio is 13.29 and the forward PE ratio is 6.93. Royalty Pharma's PEG ratio is -0.3.

    PE Ratio

    n/a
    		 13.29

    Forward PE

    n/a
    		 6.93

    PS Ratio

    n/a
    		 5.04

    Forward PS

    n/a
    		 4.3

    PB Ratio

    n/a
    		 1.64

    P/FCF Ratio

    n/a
    		 4.12

    PEG Ratio

    n/a
    		 -0.3
    Financial Ratio History

    Enterprise Valuation

    Royalty Pharma has an Enterprise Value (EV) of 18.1B.

    EV / Sales

    n/a
    		 8

    EV / EBITDA

    n/a
    		 14.01

    EV / EBIT

    n/a
    		 6.54

    EV / FCF

    n/a
    		 6.54

    Financial Position

    The company has a current ratio of 1.44, with a Debt / Equity ratio of 1.1.

    Current Ratio

    n/a
    		 1.44

    Quick Ratio

    n/a
    		 1.44

    Debt / Equity

    n/a
    		 1.1

    Debt / EBITDA

    n/a
    		 5.89

    Debt / FCF

    n/a
    		 2.75

    Interest Coverage

    n/a
    		 5.72

    Financial Efficiency

    Return on Equity is 12.37% and Return on Invested Capital is 4.64%.

    Return on Equity

    n/a
    		 12.37%

    Return on Assets

    n/a
    		 4.71%

    Return on Invested Capital

    n/a
    		 4.64%

    Revenue Per Employee

    n/a
    		 $30,186,666.67

    Profits Per Employee

    n/a
    		 $11,453,333.33

    Employee Count

    n/a
    		 75

    Asset Turnover

    n/a
    		 0.12

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 472M

    Effective Tax Rate

    n/a
    		 35.46%

    Stock Price Statistics

    The stock price has increased by 31.87% in the last 52 weeks. The beta is 0.47, so Royalty Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.47

    52-Week Price Change

    n/a
    		 31.87%

    50-Day Moving Average

    n/a
    		 32.82

    200-Day Moving Average

    n/a
    		 29.92

    Relative Strength Index (RSI)

    n/a
    		 66.31

    Average Volume (20 Days)

    n/a
    		 5,073,506

    Income Statement

    In the last 12 months, Royalty Pharma had revenue of 2.26B and earned 859M in profits. Earnings per share was 1.92.

    Revenue

    n/a
    		 2.26B

    Gross Profit

    n/a
    		 2.26B

    Operating Income

    n/a
    		 1.29B

    Net Income

    n/a
    		 859M

    EBITDA

    n/a
    		 1.29B

    EBIT

    n/a
    		 1.56B

    Earnings Per Share (EPS)

    n/a
    		 1.92
    Full Income Statement

    Balance Sheet

    The company has 929.03M in cash and 7.61B in debt, giving a net cash position of -6.68B.

    Cash & Cash Equivalents

    n/a
    		 929.03M

    Total Debt

    n/a
    		 7.61B

    Net Cash

    n/a
    		 -6.68B

    Retained Earnings

    n/a
    		 2.85B

    Total Assets

    n/a
    		 17.61B

    Working Capital

    n/a
    		 660.39M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 2.77B and capital expenditures 0, giving a free cash flow of 2.77B.

    Operating Cash Flow

    n/a
    		 2.77B

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 2.77B

    FCF Per Share

    n/a
    		 6.19
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of 57.07% and 37.94%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 57.07%

    Pretax Margin

    n/a
    		 58.79%

    Profit Margin

    n/a
    		 37.94%

    EBITDA Margin

    n/a
    		 57.07%

    EBIT Margin

    n/a
    		 57.07%

    FCF Margin

    n/a
    		 122.31%

    Dividends & Yields

    RPRX pays an annual dividend of $1.07, which amounts to a dividend yield of 2.53%.

    Dividend Per Share

    n/a
    		 $1.07

    Dividend Yield

    n/a
    		 2.53%

    Dividend Growth (YoY)

    n/a
    		 4.76%

    Payout Ratio

    n/a
    		 43.5%

    Earnings Yield

    n/a
    		 7.52%

    FCF Yield

    n/a
    		 24.25%
    Dividend Details

    Analyst Forecast

    The average price target for RPRX is $51, which is 45.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $51

    Price Target Difference

    n/a
    		 45.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $14.94

    Lynch Upside

    n/a
    		 -57.42%

    Graham Number

    n/a
    		 25.89

    Graham Upside

    n/a
    		 -26.22%

    Scores

    Altman Z-Score

    n/a
    		 2.08

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist